Exosome Diagnostics, Therapeutics and Research Tools: Global Markets
Report Scope
This report aims to provide a comprehensive study of the global market for exosome diagnostic, therapeutic, and research tools, both in terms of quantitative and qualitative data, to help readers develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace, and make informed business decisions regarding exosome products. BCC Research estimates market data for 2022 (the base year) and forecasts values for 2023 through 2028.
The scope of this study is global and covers exosome products and research tools used in the healthcare industry only. Exosome products and research tools used in other sectors, such as skincare and beauty, are beyond the scope of this report.
Report Includes
This report aims to provide a comprehensive study of the global market for exosome diagnostic, therapeutic, and research tools, both in terms of quantitative and qualitative data, to help readers develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace, and make informed business decisions regarding exosome products. BCC Research estimates market data for 2022 (the base year) and forecasts values for 2023 through 2028.
The scope of this study is global and covers exosome products and research tools used in the healthcare industry only. Exosome products and research tools used in other sectors, such as skincare and beauty, are beyond the scope of this report.
Report Includes
- 14 data tables and 77 additional tables
- Analysis of the global markets and global trends for exosome diagnostics and therapeutics, with revenue data for 2021-2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2028
- Estimate of the current market size and revenue growth prospects, along with a market share analysis based on product, application, end user and region
- Facts and figures pertaining to the market drivers, opportunities and restraints, and the impacts of macroeconomic variables
- Discussion of emerging technologies, regulations and R&D efforts
- Evaluation of new commercial opportunities in the diagnostics, therapeutics and research tools markets, and an assessment of trends, products and assay developments
- Insight into the use of exosome proteins and nucleic acids as diagnostic biomarkers and their impact on the microRNA, liquid biopsy and stem cell research industry
- Analysis of relevant patents related to exosome diagnostics and therapeutics in the U.S., Europe and Japan
- Overview of sustainability trends and ESG developments, including consumer attitudes, companies’ ESG score rankings and their ESG practices
- Analysis of the competitive landscape, including companies’ market shares, business segments, financials and product portfolios, as well as recent M&A activity and a venture funding outlook
- Company profiles of major players within the industry, including Bio-Techne, Exosomics S.p.A., and System Biosciences LLC.
CHAPTER 1 EXECUTIVE SUMMARY
Market Outlook
Scope of Report
Market Summary
CHAPTER 2 MARKET OVERVIEW
Exosome Basics
Exosome Biogenesis and Processing
Exosome Function and Physiology
Intracellular Communication
Facilitation of the Immune Response
Tissue Regeneration
Bioinformatic Databases for Exosome Research and Product Development
ExoCarta
Vesiclepedia
EVpedia
CHAPTER 3 MARKET DYNAMICS
Overview
Market Drivers
Increasing Investment in Biomedical Research
Trend Towards Precision Medicine
Technological Advancements in Exosome Research Tools
Restraints
Evolving Regulatory Landscape
Lack of Well-Characterized Exosome Standards
Opportunities
Growing Popularity in Liquid Biopsy
Benefits Over Stem Cell Therapy
Challenges
Funding Issues
CHAPTER 4 REGULATORY LANDSCAPE
U.S.
Exosome Therapeutics
Exosome Clinical Assays Development and Marketing
CHAPTER 5 EMERGING TECHNOLOGIES AND DEVELOPMENTS
Emerging Technologies
Engineered Exosomes
Microfluidic Technology
Exosome Research Services
Exosome Based Liquid Biopsy Tests
Clinical Trial Analysis
Overview
By Phases
By Funder Type
By Disease Type
By Country
Pipeline Analysis
CHAPTER 6 MARKET SEGMENTATION ANALYSIS
Segmental Breakdown
Market Analysis by Application Type
Diagnostics and Monitoring
Evaluation of the Diagnostics and Monitoring Market
Cancer
CNS Disorders and Neurodegeneration Diseases
Organ Transplantation
Cardiovascular Diseases
Others
Diagnostics and Monitoring Market Revenue
Exosome Therapeutics
Potential Therapeutic Applications
Evaluation of the Current and Potential Therapeutics Market
Key Target Indications
Research Tools and Regents
Research Tools and Reagents Market Revenue
Geographic Breakdown
North America
Europe
Asia-Pacific
Rest of the World (RoW)
CHAPTER 7 COMPETITIVE INTELLIGENCE
Overview
Exosome-Based Clinical Diagnostics Market
Market Participants in the Exosome-Based Clinical Diagnostics Market
Exosome-Based Therapeutics Market
Market Participants in the Exosome-Based Therapeutics Market
Exosome Research Tools and Reagents Market
Market Participants in the Exosome Research Tools and Reagents Market
Key Strategies
Opportunities and Challenges in the Exosome Market
CHAPTER 8 APPENDIX
Methodology
Sources/References
Acronyms
Company Profiles
ACOUSORT AB
AEGLE THERAPEUTICS
AETHLON MEDICAL INC.
ARUNA BIO INC.
BIO-TECHNE
CAPRICOR THERAPEUTICS INC.
CARIS LIFE SCIENCES
DIRECT BIOLOGICS LLC
EXOSOMICS SPA
EVOX THERAPEUTICS LTD.
KIMERA LABS
LONZA
MIR SCIENTIFIC
NANO MED
NANOSOMIX
RION
SYSTEM BIOSCIENCES LLC
Market Outlook
Scope of Report
Market Summary
CHAPTER 2 MARKET OVERVIEW
Exosome Basics
Exosome Biogenesis and Processing
Exosome Function and Physiology
Intracellular Communication
Facilitation of the Immune Response
Tissue Regeneration
Bioinformatic Databases for Exosome Research and Product Development
ExoCarta
Vesiclepedia
EVpedia
CHAPTER 3 MARKET DYNAMICS
Overview
Market Drivers
Increasing Investment in Biomedical Research
Trend Towards Precision Medicine
Technological Advancements in Exosome Research Tools
Restraints
Evolving Regulatory Landscape
Lack of Well-Characterized Exosome Standards
Opportunities
Growing Popularity in Liquid Biopsy
Benefits Over Stem Cell Therapy
Challenges
Funding Issues
CHAPTER 4 REGULATORY LANDSCAPE
U.S.
Exosome Therapeutics
Exosome Clinical Assays Development and Marketing
CHAPTER 5 EMERGING TECHNOLOGIES AND DEVELOPMENTS
Emerging Technologies
Engineered Exosomes
Microfluidic Technology
Exosome Research Services
Exosome Based Liquid Biopsy Tests
Clinical Trial Analysis
Overview
By Phases
By Funder Type
By Disease Type
By Country
Pipeline Analysis
CHAPTER 6 MARKET SEGMENTATION ANALYSIS
Segmental Breakdown
Market Analysis by Application Type
Diagnostics and Monitoring
Evaluation of the Diagnostics and Monitoring Market
Cancer
CNS Disorders and Neurodegeneration Diseases
Organ Transplantation
Cardiovascular Diseases
Others
Diagnostics and Monitoring Market Revenue
Exosome Therapeutics
Potential Therapeutic Applications
Evaluation of the Current and Potential Therapeutics Market
Key Target Indications
Research Tools and Regents
Research Tools and Reagents Market Revenue
Geographic Breakdown
North America
Europe
Asia-Pacific
Rest of the World (RoW)
CHAPTER 7 COMPETITIVE INTELLIGENCE
Overview
Exosome-Based Clinical Diagnostics Market
Market Participants in the Exosome-Based Clinical Diagnostics Market
Exosome-Based Therapeutics Market
Market Participants in the Exosome-Based Therapeutics Market
Exosome Research Tools and Reagents Market
Market Participants in the Exosome Research Tools and Reagents Market
Key Strategies
Opportunities and Challenges in the Exosome Market
CHAPTER 8 APPENDIX
Methodology
Sources/References
Acronyms
Company Profiles
ACOUSORT AB
AEGLE THERAPEUTICS
AETHLON MEDICAL INC.
ARUNA BIO INC.
BIO-TECHNE
CAPRICOR THERAPEUTICS INC.
CARIS LIFE SCIENCES
DIRECT BIOLOGICS LLC
EXOSOMICS SPA
EVOX THERAPEUTICS LTD.
KIMERA LABS
LONZA
MIR SCIENTIFIC
NANO MED
NANOSOMIX
RION
SYSTEM BIOSCIENCES LLC
LIST OF TABLES
Summary Table: Global Market for Exosome Diagnostics, Therapeutics and Research Tools, by Application, Through 2028
Table 1: Steps in Exosome Biogenesis and Processing
Table 2: Comparison of Databases for Exosome Studies
Table 3: Key Properties of CTC vs. cfDNA vs. Exosomes
Table 4: FDA Drug Approval Process
Table 5: Multiple Paths to Market for Biomarker Tests
Table 6: Phase 1 Above Active and Completed Clinical Trials for Potential Exosome Therapeutic Candidates
Table 7: Why Exosomes as Biomarkers
Table 8: Examples of Exosomal Proteins for Clinical Diagnostic Applications
Table 9: Examples of Exosomal miRNA for Clinical Diagnostic Applications
Table 10: Exosome-Based Commercial Clinical Assays for Prostate Cancer
Table 11: Selected Exosome-Based Clinical Assays that Are Currently Undergoing Clinical Validation
Table 12: Global Market for Exosome Diagnostics and Monitoring, Through 2028
Table 13: Examples of Engineering Exosome for Cargo Delivery
Table 14: Intrinsic Therapeutic Activity of Exosomes
Table 15: Comparison of Cell and Exosome Therapies
Table 16: Global Market for Exosome Therapeutics, Through 2028
Table 17: Exosome Clinical Studies for ARDS
Table 18: Exosome Clinical Studies for RP
Table 19: Exosome Clinical Studies for Skin Conditions
Table 20: Exosome Clinical Studies for Autoimmune and Inflammatory Diseases
Table 21: Exosome Clinical Studies for Other Conditions
Table 22: Main Steps in the Exosome Research Approach
Table 23: Methods for Exosome Isolation
Table 24: Comparison of Exosome Isolation and Purification Methods
Table 25: Examples of Commercially Available Exosome Isolation and Purification Research Tools
Table 26: Methods for Exosome Detection and Analysis
Table 27: Important Antibodies for Exosome Research
Table 28: Examples of Commercially Available Exosome Engineering Tools
Table 29: Global Market for Exosome Research Tools and Reagents, Through 2028
Table 30: Global Market for Exosome Diagnostics, Therapeutics and Research Tools and Reagents, by Region, Through 2028
Table 31: North American Market for Exosome Diagnostics, Therapeutics and Research Tools and Reagents, by Application, Through 2028
Table 32: European Market for Exosome Diagnostics, Therapeutics and Research Tools and Reagents, by Application, Through 2028
Table 33: Asia-Pacific Market for Exosome Diagnostics, Therapeutics and Research Tools and Reagents, Through 2028
Table 34: RoW Market for Exosome Diagnostics, Therapeutics and Research Tools and Reagents, Through 2028
Table 35: Key Market Participants in Exosome-based Clinical Assays Market
Table 36: Key Market Participants in Exosome-based Therapeutics Sector
Table 37: Main Market Participants in Exosome Research Tools and Reagents
Table 38: Selected Collaborations/Partnerships in the Exosome Market
Table 39: Glossary of Terms Used in Exosome Diagnostics and Therapeutics: Global Markets
Table 40: AcouSort AB: Company Snapshot
Table 41: AcouSort AB: Financial Performance, FY 2021 and 2022
Table 42: AcouSort AB: Product Portfolio
Table 43: AcouSort AB: News/Key Developments, 2022
Table 44: Aegle Therapeutics: Company Snapshot
Table 45: Aegle Therapeutics: Product Portfolio
Table 46: Aethlon Medical Inc.: Company Snapshot
Table 47: Aethlon Medical Inc.: Financial Performance, FY 2022 and 2023
Table 48: Aethlon Medical Inc.: Product Portfolio
Table 49: Aethlon Medical Inc.: News/Key Developments, 2022 and 2023
Table 50: Aruna Bio Inc.: Company Snapshot
Table 51: Aruna Bio Inc.: Product Portfolio
Table 52: Aruna Bio Inc.: News/Key Developments, 2024
Table 53: Bio-Techne: Company Snapshot
Table 54: Bio-Techne: Financial Performance, FY 2022 and 2023
Table 55: Bio-Techne: Product Portfolio
Table 56: Bio-Techne: News/Key Developments, 2022 and 2023
Table 57: Capricor Therapeutics Inc.: Company Snapshot
Table 58: Capricor Therapeutics Inc.: Financial Performance, FY 2022 and 2023
Table 59: Capricor Therapeutics Inc.: Product Portfolio
Table 60: Capricor Therapeutics Inc.: News/Key Developments, 2024
Table 61: Caris Life Sciences: Company Snapshot
Table 62: Caris Life Sciences: Product Portfolio
Table 63: Caris Life Sciences: News/Key Developments, 2022
Table 64: Direct Biologics LLC: Company Snapshot
Table 65: Direct Biologics LLC: Product Portfolio
Table 66: Direct Biologics LLC: News/Key Developments, 2022 and 2023
Table 67: Exosomics SPA: Company Snapshot
Table 68: Exosomics SPA: Product Portfolio
Table 69: EVOX Therapeutics Ltd.: Company Snapshot
Table 70: Evox Therapeutics Ltd.: Product Portfolio
Table 71: Evox Therapeutics Ltd.: News/Key Developments, 2021-2023
Table 72: Kimera Labs: Company Snapshot
Table 73: Kimera Labs: Product Portfolio
Table 74: Kimera Labs: News/Key Developments, 2023
Table 75: Lonza: Company Snapshot
Table 76: Lonza: Financial Performance, FY 2022 and 2023
Table 77: Lonza: Product Portfolio
Table 78: Lonza: News/Key Developments, 2021
Table 79: miR Scientific: Company Snapshot
Table 80: miR Scientific: Product Portfolio
Table 81: miR Scientific: News/Key Developments, 2022 and 2023
Table 82: Nano Med: Company Snapshot
Table 83: Nano Med: Product Portfolio
Table 84: NanoSomiX: Company Snapshot
Table 85: NanoSomiX: Product Portfolio
Table 86: Rion: Company Snapshot
Table 87: Rion: Product Portfolio
Table 88: Rion: News/Key Developments, 2023 and 2024
Table 89: System Biosciences LLC: Company Snapshot
Table 90: System Biosciences LLC: Product Portfolio
Summary Table: Global Market for Exosome Diagnostics, Therapeutics and Research Tools, by Application, Through 2028
Table 1: Steps in Exosome Biogenesis and Processing
Table 2: Comparison of Databases for Exosome Studies
Table 3: Key Properties of CTC vs. cfDNA vs. Exosomes
Table 4: FDA Drug Approval Process
Table 5: Multiple Paths to Market for Biomarker Tests
Table 6: Phase 1 Above Active and Completed Clinical Trials for Potential Exosome Therapeutic Candidates
Table 7: Why Exosomes as Biomarkers
Table 8: Examples of Exosomal Proteins for Clinical Diagnostic Applications
Table 9: Examples of Exosomal miRNA for Clinical Diagnostic Applications
Table 10: Exosome-Based Commercial Clinical Assays for Prostate Cancer
Table 11: Selected Exosome-Based Clinical Assays that Are Currently Undergoing Clinical Validation
Table 12: Global Market for Exosome Diagnostics and Monitoring, Through 2028
Table 13: Examples of Engineering Exosome for Cargo Delivery
Table 14: Intrinsic Therapeutic Activity of Exosomes
Table 15: Comparison of Cell and Exosome Therapies
Table 16: Global Market for Exosome Therapeutics, Through 2028
Table 17: Exosome Clinical Studies for ARDS
Table 18: Exosome Clinical Studies for RP
Table 19: Exosome Clinical Studies for Skin Conditions
Table 20: Exosome Clinical Studies for Autoimmune and Inflammatory Diseases
Table 21: Exosome Clinical Studies for Other Conditions
Table 22: Main Steps in the Exosome Research Approach
Table 23: Methods for Exosome Isolation
Table 24: Comparison of Exosome Isolation and Purification Methods
Table 25: Examples of Commercially Available Exosome Isolation and Purification Research Tools
Table 26: Methods for Exosome Detection and Analysis
Table 27: Important Antibodies for Exosome Research
Table 28: Examples of Commercially Available Exosome Engineering Tools
Table 29: Global Market for Exosome Research Tools and Reagents, Through 2028
Table 30: Global Market for Exosome Diagnostics, Therapeutics and Research Tools and Reagents, by Region, Through 2028
Table 31: North American Market for Exosome Diagnostics, Therapeutics and Research Tools and Reagents, by Application, Through 2028
Table 32: European Market for Exosome Diagnostics, Therapeutics and Research Tools and Reagents, by Application, Through 2028
Table 33: Asia-Pacific Market for Exosome Diagnostics, Therapeutics and Research Tools and Reagents, Through 2028
Table 34: RoW Market for Exosome Diagnostics, Therapeutics and Research Tools and Reagents, Through 2028
Table 35: Key Market Participants in Exosome-based Clinical Assays Market
Table 36: Key Market Participants in Exosome-based Therapeutics Sector
Table 37: Main Market Participants in Exosome Research Tools and Reagents
Table 38: Selected Collaborations/Partnerships in the Exosome Market
Table 39: Glossary of Terms Used in Exosome Diagnostics and Therapeutics: Global Markets
Table 40: AcouSort AB: Company Snapshot
Table 41: AcouSort AB: Financial Performance, FY 2021 and 2022
Table 42: AcouSort AB: Product Portfolio
Table 43: AcouSort AB: News/Key Developments, 2022
Table 44: Aegle Therapeutics: Company Snapshot
Table 45: Aegle Therapeutics: Product Portfolio
Table 46: Aethlon Medical Inc.: Company Snapshot
Table 47: Aethlon Medical Inc.: Financial Performance, FY 2022 and 2023
Table 48: Aethlon Medical Inc.: Product Portfolio
Table 49: Aethlon Medical Inc.: News/Key Developments, 2022 and 2023
Table 50: Aruna Bio Inc.: Company Snapshot
Table 51: Aruna Bio Inc.: Product Portfolio
Table 52: Aruna Bio Inc.: News/Key Developments, 2024
Table 53: Bio-Techne: Company Snapshot
Table 54: Bio-Techne: Financial Performance, FY 2022 and 2023
Table 55: Bio-Techne: Product Portfolio
Table 56: Bio-Techne: News/Key Developments, 2022 and 2023
Table 57: Capricor Therapeutics Inc.: Company Snapshot
Table 58: Capricor Therapeutics Inc.: Financial Performance, FY 2022 and 2023
Table 59: Capricor Therapeutics Inc.: Product Portfolio
Table 60: Capricor Therapeutics Inc.: News/Key Developments, 2024
Table 61: Caris Life Sciences: Company Snapshot
Table 62: Caris Life Sciences: Product Portfolio
Table 63: Caris Life Sciences: News/Key Developments, 2022
Table 64: Direct Biologics LLC: Company Snapshot
Table 65: Direct Biologics LLC: Product Portfolio
Table 66: Direct Biologics LLC: News/Key Developments, 2022 and 2023
Table 67: Exosomics SPA: Company Snapshot
Table 68: Exosomics SPA: Product Portfolio
Table 69: EVOX Therapeutics Ltd.: Company Snapshot
Table 70: Evox Therapeutics Ltd.: Product Portfolio
Table 71: Evox Therapeutics Ltd.: News/Key Developments, 2021-2023
Table 72: Kimera Labs: Company Snapshot
Table 73: Kimera Labs: Product Portfolio
Table 74: Kimera Labs: News/Key Developments, 2023
Table 75: Lonza: Company Snapshot
Table 76: Lonza: Financial Performance, FY 2022 and 2023
Table 77: Lonza: Product Portfolio
Table 78: Lonza: News/Key Developments, 2021
Table 79: miR Scientific: Company Snapshot
Table 80: miR Scientific: Product Portfolio
Table 81: miR Scientific: News/Key Developments, 2022 and 2023
Table 82: Nano Med: Company Snapshot
Table 83: Nano Med: Product Portfolio
Table 84: NanoSomiX: Company Snapshot
Table 85: NanoSomiX: Product Portfolio
Table 86: Rion: Company Snapshot
Table 87: Rion: Product Portfolio
Table 88: Rion: News/Key Developments, 2023 and 2024
Table 89: System Biosciences LLC: Company Snapshot
Table 90: System Biosciences LLC: Product Portfolio
LIST OF FIGURES
Summary Figure: Global Market for Exosome Diagnostics, Therapeutics and Research Tools, by Application, 2021-2028
Figure 1: Key Cellular Process under Investigation for Potential Role of Exosomes
Figure 2: Market Dynamics of Exosome Diagnostics, Therapeutics and Research Tools
Figure 3: PubMed Article Count: “Exosome,” 2017-2023
Figure 4: Interest Over Time on Google Trends: “Exosome,” 2017-2023
Figure 5: Exosomes: Scalable Production
Figure 6: Emerging Technologies in the Exosome Market
Figure 7: Exosome Clinical Studies, by Phase, as of January 2024
Figure 8: Exosome Clinical Studies, by Funder Type, January 2024
Figure 9: Exosome Clinical Studies, by Disease Type, January 2024
Figure 10: Exosome Clinical Studies, by Country, January 2024
Figure 11: Potential Clinical Applications of Exosome-based Assays
Figure 12: Global Market for Exosome Diagnostics and Monitoring, 2021-2028
Figure 13: Global Market for Exosome Therapeutics, 2021-2028
Figure 14: Exosome Research Process and Product Uses
Figure 15: Global Market for Exosome Research Tools and Reagents, 2021–2028
Figure 16: Global Market Shares of Exosome Diagnostics, Therapeutics and Research Tools and Reagents, by Region, 2022
Figure 17: Investment in Grants for Biomedical Research, by Region, 2020
Figure 18: Opportunities and Challenges in the Exosome Market
Figure 19: Bio-Techne: Revenue Share, by Business Unit, FY 2023
Figure 20: Bio-Techne: Revenue Share, by Country/Region, FY 2023
Figure 21: Lonza: Revenue Share, by Business Unit, FY 2023
Summary Figure: Global Market for Exosome Diagnostics, Therapeutics and Research Tools, by Application, 2021-2028
Figure 1: Key Cellular Process under Investigation for Potential Role of Exosomes
Figure 2: Market Dynamics of Exosome Diagnostics, Therapeutics and Research Tools
Figure 3: PubMed Article Count: “Exosome,” 2017-2023
Figure 4: Interest Over Time on Google Trends: “Exosome,” 2017-2023
Figure 5: Exosomes: Scalable Production
Figure 6: Emerging Technologies in the Exosome Market
Figure 7: Exosome Clinical Studies, by Phase, as of January 2024
Figure 8: Exosome Clinical Studies, by Funder Type, January 2024
Figure 9: Exosome Clinical Studies, by Disease Type, January 2024
Figure 10: Exosome Clinical Studies, by Country, January 2024
Figure 11: Potential Clinical Applications of Exosome-based Assays
Figure 12: Global Market for Exosome Diagnostics and Monitoring, 2021-2028
Figure 13: Global Market for Exosome Therapeutics, 2021-2028
Figure 14: Exosome Research Process and Product Uses
Figure 15: Global Market for Exosome Research Tools and Reagents, 2021–2028
Figure 16: Global Market Shares of Exosome Diagnostics, Therapeutics and Research Tools and Reagents, by Region, 2022
Figure 17: Investment in Grants for Biomedical Research, by Region, 2020
Figure 18: Opportunities and Challenges in the Exosome Market
Figure 19: Bio-Techne: Revenue Share, by Business Unit, FY 2023
Figure 20: Bio-Techne: Revenue Share, by Country/Region, FY 2023
Figure 21: Lonza: Revenue Share, by Business Unit, FY 2023
